Announced
Financials
Sources
Tags
Friendly
France
Single Bidder
Private
postiotics solutions
pharmaceutical manufacturing
Acquisition
Cross Border
Majority
Pending
Pharmaceuticals
Synopsis
Royal DSM, a global science-based leader in health, nutrition and bioscience, agreed to acquire Adare Biome, a pioneer in the development and manufacturing of postbiotics, from Adare Pharma Solutions, a global technology-driven CDMO providing end-to-end integrated services, for €275m. “DSM would be the ideal company to take Adare Biome to a new level and realize the growth potential of postbiotics. They have the infrastructure and strong commercialization and science capabilities to scale the significant scientific research achieved over the years and DSM’s mission to create healthier lives for all will resonate strongly with the team,” Tom Sellig, Adare Pharma Solutions CEO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.